Lv51
1470 积分 2025-04-25 加入
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
2小时前
已完结
Recent Advances in the Management of Metastatic Prostate Cancer
3天前
已关闭
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)
14天前
已完结
Rho GTPase Activating Protein 9 (ARHGAP9) in Human Cancers
20天前
已完结
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
23天前
已完结
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer
23天前
已完结
Molecular glues targeting GSPT1 in cancers: A potent therapy
24天前
已完结
GSPT1 degraders: research progress, development strategies and challenges
28天前
已完结
The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions
1个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1个月前
已完结
皖公网安备34019202002308
